SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

OMXC 20 NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

Lundbeck: Click to view the issuer\'s details

Last update : 16/08/2018  >View issuer details

2019.11.05 | Periodic information / 3rd Quarter Information

English version PDF Mail

puce Lundbeck : Financial report for the period 1 January to 30 September 2019 - PDF (780Kb)

2019.08.14 | Periodic information / Half-Year Financial Report

English version PDF Mail

puce Lundbeck : Financial report for the period 1 January to 30 June 2019 - PDF (754Kb)

2019.05.22 | 10:38 | Share History / Voting Rights and Number of Shares

English version HTML (w) Mail

puce Lundbeck increases its share capital by 26,098 shares (0.0131 % of outstanding shares) as a result of exercise of employee warrants - HTML (w)

2019.05.21 | 13:48 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties - HTML (w)

2019.05.20 | 14:18 | Share History / Voting Rights and Number of Shares

English version HTML (w) Mail

puce Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties - HTML (w)

2019.05.09 | 16:01 | Share History / Voting Rights and Number of Shares

English version HTML (w) Mail

puce Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties - HTML (w)

2019.05.08 | 07:24 | Permanent Information Releases / Sales and Revenues

English version HTML (w) Mail

puce Double-digit growth for all strategic brands and DKK 4,234 million in revenue and DKK 1,200 million in EBIT - HTML (w)

2019.05.08 | Periodic information / 1st Quarter Information

English version PDF Mail

puce Lundbeck : Financial report for the period 1 January to 31 March 2019 - PDF (635Kb)

2019.05.06 | 07:27 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Lundbeck to acquire Abide Therapeutics, adding a unique discovery platform and a lead compound in an exploratory phase IIa program for Tourette’s - HTML (w)

2019.03.26 | 14:16 | Annual General Meeting / AGM

English version HTML (w) Mail

puce Lundbeck held its Annual General Meeting on 26 March 2019 at the company’s registered office - HTML (w)

2019.03.08 | 09:00 | Permanent Information Releases / Appointments

English version HTML (w) Mail

puce Lundbeck appoints Keld Flintholm Jørgensen as EVP and Chief Business Officer - HTML (w)

2019.02.28 | 09:15 | Annual General Meeting / Preparatory Documents

English version HTML (w) Mail

puce Notice of Annual General Meeting - HTML (w)

2019.02.18 | 09:46 | Permanent Information Releases / Operations

English version HTML (w) Mail

puce Lundbeck increases its share capital by 5,631 shares (0.0028 % of outstanding shares) as a result of exercise of employee warrants - HTML (w)

2019.02.14 | 15:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Lundbeck and Otsuka report phase III data evaluating brexpiprazole for the treatment of manic episodes associated with bipolar I disorder - HTML (w)

2019.02.05 | 07:52 | Periodic information / Annual Financial Report

English version HTML (w) Mail

puce Annual Report 2018 for H.Lundbeck A/S - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 / Doc nb : 99